Navigation Links
AutoGenomics New RVP Assay Addresses Current Challenge to Detect Flu A - Swine H1N1
Date:5/21/2009

CARLSBAD, Calif., May 21 /PRNewswire/ -- AutoGenomics, a leader in developing automated molecular testing solutions, announced today that a Canadian team comprised of the Canada Research Chair in Medical Genomics, Professor Jacques Corbeil and Canada Research Chair on new viruses and antiviral resistance, Professor Guy Boivin has used its enhanced respiratory virus panel assay to test for the presence of the new Flu A - Swine H1N1 virus. "The assay for research use only detected the presence of both the circulating Flu A strains and the new Flu A - H1N1 strain," said Dr. Corbeil. He further stated that "the assay distinguished the new strain from the others as well as determined the presence of an additional 24 viruses that could potentially co-infect the patients, a factor that may increase the severity of the disease."

"This assay will be of great help in the coming flu seasons and facilitate improving hospital control strategies to understand the role of co- infections in the severity of swine flu cases and enable the selection of antiviral agents in the management of influenza infections," said Dr. Boivin.

The tests, conducted at the CHUL hospital affiliated with Laval University were part of an effort from the Canadian Institute of Health Research to promote research in this area of important societal need.

About AutoGenomics

AutoGenomics, Inc., a privately held company based in Carlsbad, CA, has developed the first automated, microarray based multiplexing diagnostic platforms that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious disease, cancer and pharmacogenetics. With the discovery of genes and their link to various disease states the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed leading to the era of personalized medicine. www.autogenomics.com.


'/>"/>
SOURCE AutoGenomics
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. AutoGenomics Invited to Present at the 2009 JPMorgan Healthcare Conference
2. AutoGenomics to Present at Cowen Health Care Conference on March 17, 2008
3. AutoGenomics Invited to Present at the JPMorgan Healthcare Conference
4. BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management
5. Genomic Health Announces Positive Preliminary Results from QUASAR Validation Study of Oncotype DX(R) Colon Cancer Assay
6. Polycystic Kidney Disease Assay at Cornell University Uses Transgenomics Surveyor Nuclease & WAVE Technology
7. Intrinsic Bioprobes, Inc. Enters into a $1.27M Contract with the National Cancer Institute to Develop Multiplex Mass Spectrometric Immunoassays for Detection of Low Abundance Cancer-Related Proteins
8. Celsis Introduces ReACT(TM) RNA-Based Microbial Detection Assays
9. Odyssey Thera Granted U.S. Patent for Novel GPCR Assay Strategy
10. SAFC Pharma Augments Assay Development Capabilities
11. Burnham Announces Assay Development and License Agreement with Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... ... NDA Partners Chairman Carl Peck, MD , announced today that John W. ... Center for Devices and Radiological Health and recognized leader in the medical device, pharmaceutical ... his FDA experience, Dr. Sheets served in senior technical leadership roles in a series ...
(Date:8/21/2017)... USA (PRWEB) , ... August 20, 2017 , ... ... the Journal of Biomedical Optics (JBO) starting 1 January 2018. The journal is ... of Biomedical Optics publishes papers on the use of modern optical technology for ...
(Date:8/21/2017)... ... August 21, 2017 , ... The team at ... educational webinar, in which attendees will learn about the assembly and topological architecture ... with an overview of the development and validation of new high-quality recombinant monoclonal ...
(Date:8/17/2017)... Westlake Village, CA (PRWEB) , ... August 17, ... ... biopsy technology for cancer research and personalized medicine, today announced the launch of ... in Kansas City, Missouri. The study’s goal is to evaluate the potential for ...
Breaking Biology Technology:
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
Breaking Biology News(10 mins):